The albumin-bilirubin (ALBI) model in hepatocellular carcinoma (HCC) may better predict hepatic failure in patients with traditionally low-risk cirrhosis following definitive stereotactic body radiotherapy (SBRT)
S. Hasan, S. Abel, I. Jan, T. Uemura, N. Thai, A. Kirichenko
{"title":"The albumin-bilirubin (ALBI) model in hepatocellular carcinoma (HCC) may better predict hepatic failure in patients with traditionally low-risk cirrhosis following definitive stereotactic body radiotherapy (SBRT)","authors":"S. Hasan, S. Abel, I. Jan, T. Uemura, N. Thai, A. Kirichenko","doi":"10.1007/s13566-018-0354-7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":89815,"journal":{"name":"Journal of radiation oncology","volume":"67 1","pages":"247-253"},"PeriodicalIF":0.0000,"publicationDate":"2018-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of radiation oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13566-018-0354-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
